Abstract

Maternofetal stress induces fetal programming that restricts skeletal muscle growth capacity and metabolic function, resulting in intrauterine growth restriction (IUGR) of the fetus. This thrifty phenotype aids fetal survival but also yields reduced muscle mass and metabolic dysfunction after birth. Consequently, IUGR-born individuals are at greater lifelong risk for metabolic disorders that reduce quality of life. In livestock, IUGR-born animals exhibit poor growth efficiency and body composition, making these animals more costly and less valuable. Specifically, IUGR-associated programming causes a greater propensity for fat deposition and a reduced capacity for muscle accretion. This, combined with metabolic inefficiency, means that these animals produce less lean meat from greater feed input, require more time on feed to reach market weight, and produce carcasses that are of less quality. Despite the health and economic implications of IUGR pathologies in humans and food animals, knowledge regarding their specific underlying mechanisms is lacking. However, recent data indicate that adaptive programing of adrenergic sensitivity in multiple tissues is a contributing factor in a number of IUGR pathologies including reduced muscle mass, peripheral insulin resistance, and impaired glucose metabolism. This review highlights the findings that support the role for adrenergic programming and how it relates to the lifelong consequences of IUGR, as well as how dysfunctional adrenergic signaling pathways might be effective targets for improving outcomes in IUGR-born offspring.

Highlights

  • Intrauterine growth restriction (IUGR) is the result of fetal developmental programming aimed at increasing the chances of surviving poor intrauterine conditions by promoting thrifty growth and metabolism

  • There is a broad range of causes for intrauterine growth restriction (IUGR) in livestock and humans that result in varying degrees of fetal growth restriction, which have been reviewed in greater detail elsewhere (Greenwood and Cafe, 2007; Beede et al, 2019)

  • Neonatal, and juvenile lambs, this manifested in reductions of up to 50% in hindlimb-specific glucose oxidation rates, which were concomitant with increased blood lactate concentrations et al, 2016)

Read more

Summary

INTRODUCTION

Intrauterine growth restriction (IUGR) is the result of fetal developmental programming aimed at increasing the chances of surviving poor intrauterine conditions by promoting thrifty growth and metabolism. The establishment and characterization of several animal models for IUGR provides the opportunity to study the fetal programming mechanisms underlying IUGR pathologies in livestock and humans (Reynolds et al, 2010; Beede et al, 2019) These mechanisms are not comprehensively understood, but recent findings implicate developmental changes in adrenergic regulation of muscle and other tissues that are relevant to nutrient utilization, metabolic homeostasis, and peripheral tissue growth (Yates et al, 2011, 2019; Cadaret et al, 2019c; Gibbs et al, 2020). We highlight the evidence for adrenergic adaptations in IUGR tissues and their roles in impaired post-natal muscle growth and metabolic dysfunction

Etiology of IUGR in Livestock and Humans
Adrenergic Regulation of Growth and Metabolism
Chronic Catecholamine Exposure Alters Adrenergic Programming in IUGR Tissues
Targeting Adrenergic Adaptations Improves IUGR Outcomes
Findings
The IUGR Phenotype Does Not Result From Adrenergic Programming Alone
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call